Global Primary Progressive Multiple Sclerosis Treatment Market Analysis 2016-2020 and Forecast 2021-2026

Table of Contents
1 Industry Overview
1.1 Primary Progressive Multiple Sclerosis Treatment Industry
Figure Primary Progressive Multiple Sclerosis Treatment Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Primary Progressive Multiple Sclerosis Treatment
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Primary Progressive Multiple Sclerosis Treatment
1.2.2 Downstream
Table Application Segment of Primary Progressive Multiple Sclerosis Treatment
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Primary Progressive Multiple Sclerosis Treatment Market by Type
3.1 By Type
3.1.1 ApE
Table Major Company List of ApE
3.1.2 Biotin
Table Major Company List of Biotin
3.1.3 GZ-402668
Table Major Company List of GZ-402668
3.1.4 Ibudilast
Table Major Company List of Ibudilast
3.1.5 Idebenone
Table Major Company List of Idebenone
3.1.6 Laquinimod Sodium
Table Major Company List of Laquinimod Sodium
3.1.7 Others
Table Major Company List of Others
3.2 Market Size
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Type, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2016-2020, by Type, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Type, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Type, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.1.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.1.2 F. Hoffmann-La Roche Ltd. Products & Services
4.1.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Genzyme Corporation (Company Profile, Sales Data etc.)
4.2.1 Genzyme Corporation Profile
Table Genzyme Corporation Overview List
4.2.2 Genzyme Corporation Products & Services
4.2.3 Genzyme Corporation Business Operation Conditions
Table Business Operation of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Glialogix, Inc. (Company Profile, Sales Data etc.)
4.3.1 Glialogix, Inc. Profile
Table Glialogix, Inc. Overview List
4.3.2 Glialogix, Inc. Products & Services
4.3.3 Glialogix, Inc. Business Operation Conditions
Table Business Operation of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Kyorin Pharmaceutical Co., Ltd. (Company Profile, Sales Data etc.)
4.4.1 Kyorin Pharmaceutical Co., Ltd. Profile
Table Kyorin Pharmaceutical Co., Ltd. Overview List
4.4.2 Kyorin Pharmaceutical Co., Ltd. Products & Services
4.4.3 Kyorin Pharmaceutical Co., Ltd. Business Operation Conditions
Table Business Operation of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 MedDay SA (Company Profile, Sales Data etc.)
4.5.1 MedDay SA Profile
Table MedDay SA Overview List
4.5.2 MedDay SA Products & Services
4.5.3 MedDay SA Business Operation Conditions
Table Business Operation of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Santhera Pharmaceuticals Holding AG (Company Profile, Sales Data etc.)
4.6.1 Santhera Pharmaceuticals Holding AG Profile
Table Santhera Pharmaceuticals Holding AG Overview List
4.6.2 Santhera Pharmaceuticals Holding AG Products & Services
4.6.3 Santhera Pharmaceuticals Holding AG Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Teva Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)
4.7.1 Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Overview List
4.7.2 Teva Pharmaceutical Industries Ltd. Products & Services
4.7.3 Teva Pharmaceutical Industries Ltd. Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue 2016-2020, by Company, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share in 2020, by Company, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume 2016-2020, by Company, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2020
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Market Concentration, in 2020
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment MMarket Concentration, in 2020
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2020
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2016-2020, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2016-2020, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2016-2020, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2021-2026, by Application, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Market Growth 2021-2026, by Application, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Market Share in 2026, by Application, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2021-2026, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Growth 2021-2026, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Primary Progressive Multiple Sclerosis Treatment Production 2016-2020, by Region, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Region, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2016-2020, by Region, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Region, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Region, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Table
1. Table Upstream Segment of Primary Progressive Multiple Sclerosis Treatment
2. Table Application Segment of Primary Progressive Multiple Sclerosis Treatment
3. Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Biotin
5. Table Major Company List of GZ-402668
6. Table Major Company List of Ibudilast
7. Table Major Company List of Idebenone
8. Table Major Company List of Laquinimod Sodium
9. Table Major Company List of Others
10. Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Type, in USD Million
11. Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Type, in Volume
12. Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Type, in USD Million
13. Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Type, in Volume
14. Table F. Hoffmann-La Roche Ltd. Overview List
15. Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Genzyme Corporation Overview List
17. Table Business Operation of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Glialogix, Inc. Overview List
19. Table Business Operation of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Kyorin Pharmaceutical Co., Ltd. Overview List
21. Table Business Operation of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table MedDay SA Overview List
23. Table Business Operation of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Santhera Pharmaceuticals Holding AG Overview List
25. Table Business Operation of Santhera Pharmaceuticals Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Teva Pharmaceutical Industries Ltd. Overview List
27. Table Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue 2016-2020, by Company, in USD Million
29. Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share 2016-2020, by Company, in USD Million
30. Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume 2016-2020, by Company, in Volume
31. Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share 2016-2020, by Company, in Volume
32. Table Regional Demand Comparison List
33. Table Major Application in Different Regions
34. Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2021-2026, by Application, in USD Million
35. Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2021-2026, by Application, in Volume
36. Table Primary Progressive Multiple Sclerosis Treatment Market Growth 2021-2026, by Application, in Volume
37. Table Primary Progressive Multiple Sclerosis Treatment Market Share in 2026, by Application, in Volume
38. Table Primary Progressive Multiple Sclerosis Treatment Production 2016-2020, by Region, in USD Million
39. Table Primary Progressive Multiple Sclerosis Treatment Production 2016-2020, by Region, in Volume
40. Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Region, in USD Million
41. Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2016-2020, by Region, in USD Million
42. Table Global Primary Progressive Multiple Sclerosis Treatment Market 2016-2020, by Region, in Volume
43. Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2016-2020, by Region, in Volume
44. Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
45. Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
46. Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
47. Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
48. Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
49. Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
50. Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
51. Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
52. Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in USD Million
53. Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2016-2020, by Country, in Volume
54. Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Region, in USD Million
55. Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2021-2026, by Region, in Volume
56. Table Price Factors List

List of Figure
1. Figure Primary Progressive Multiple Sclerosis Treatment Industry Chain Structure
2. Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2016-2020, by Type, in Volume
4. Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2020
7. Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Market Concentration, in 2020
8. Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment MMarket Concentration, in 2020
9. Figure South America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2020
10. Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2020
11. Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2016-2020, in USD Million
12. Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2016-2020, in Volume
13. Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2016-2020, in USD Million
14. Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2016-2020, in Volume
15. Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2016-2020, in USD Million
16. Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2016-2020, in Volume
17. Figure Primary Progressive Multiple Sclerosis Treatment Market Growth 2021-2026, by Application, in USD Million
18. Figure Primary Progressive Multiple Sclerosis Treatment Market Share in 2026, by Application, in USD Million
19. Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
20. Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
21. Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
25. Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
26. Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview